News & Events / Home

X-Linked Carrier Survey is now open

The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever international

X-Linked Carrier Surveys are now available! We are excited to launch this survey project in collaboration with the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Immune Deficiency Foundation (IDF).

Independent study:SARS-CoV-2 infection in patients with GATA2 deficiency

survey GATA2 Covid Docx, 128.96 kB Dear E...

Deciphering the immune response against human papillomavirus infection using imaging mass cytometry

Human papillomaviruses (HPVs) are responsible of approximately 5% of cancers worldwide, in particular cervical cancer in women. They are also responsible of recalcitrant warts, and devastating benign tumors such as Buschke-Lowenstein tumor and tree ma...

Independent Survey: SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies

Dear ESID Member, We at ESID Board want to pay your immediate attention to an ongoing independent survey by the COVID Human Genetic Effort on the clinical characteristics of SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies. We...

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.

SARS CoV2, COVID19 and PIDs - survey for clinicians

Dear colleagues, on behalf of the ESID Society we would like to ask for your input in this global initiative and to fill out the SARS CoV2, COVID19 and PIDs Survey for clinicians.

The COVID Human Genetic Effort

Dear Friends and Colleagues,
Please find here a study proposal on behalf of Jean-Laurent Casanova, Lab of Human Genetics of Infectious Diseases, The Rockefeller University & HHMI, New York - Necker Hospital for Sick Children & INSERM, Paris.

COPID19. Worldwide survey of COVID-19 in PID patients

With the emergence of SARS-CoV-2 and the COVID-19 pandemic, there is an urgent need to understand the impact of infection on immunodeficient individuals.

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed here.

ESID 2020 Juniors Workshop Call for Applications - Deadline Extended

Time flies and ESID meeting 2020 is coming closer!

Due to the huge success and great feedback we have received throughout the last few years; we are now working on the fifth edition of the Juniors Workshop:“Pitfalls in PID. Expect the Unexpected” which will take place on FRIDAY 16th OCTOBER (see the latest version of the programme here).